Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors

Comprehensive Toxicology, Second Edition

Volumn 9, Issue , 2010, Pages 383-402

  Boelsterli, U A ^a   Kashimshetty, R ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012861790     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-046884-6.01015-0     Document Type: Chapter

References (187)

1. Aithal G.P., Day C.P. Clin. Liver Dis. 2007, 11:563-575.
2. Aithal G.P., Day C.P., Leathart J.B.S., Daly A.K. Pharmacogenetics 2000, 10:511-518.
3. Aithal G.P., Ramsay L., Daly A.K., Sonchit N., Leathart J.B.S., Alexander G., Kenna J.G., Caldwell J., Day C.P. Hepatology 2004, 39:1430-1440.
4. Amacher D.E. Curr. Med. Chem. 2005, 12:1829-1839.
5. Andrade R.J., Lucena M.I., Garcia-Cortes M., Garcia-Ruiz E., Fernandez-Bonilla E., Vazquez L. Am. J. Gastroenterol. 2002, 97:1854-1855.
6. Armstrong J.S. BioEssays 2006, 28:253-260.
7. Attri S., Rana S.V., Vaiphie K., Katyal R., Sodhi C.P., Kanwar S., Singh K. Indian J. Exp. Biol. 2001, 39:436-440.
8. Banks A.T., Zimmerman H.J., Ishak K.G., Harter J.G. Hepatology 1995, 22:820-827.
9. Barbaro G., Di Lorenzo G., Asti A., Ribersani M., Belloni G., Grisorio B., Filice G., Barbarini G. Am. J. Gastroenterol. 1999, 94:2198-2205.
10. Bernardi P., Petronilli V. J. Bioenerg. Biomembr. 1996, 28:131-138.
11. Berson A., Cazanave S., Descatoire V., Tinel M., Grodet A., Wolf C., Feldmann G., Pessayre D. J. Pharmacol. Exp. Ther. 2006, 318:444-454.
12. Berson A., Wolf C., Chachaty C., Fisch C., Fau D., Eugene D., Loeper J., Gauthier J.C., Beaune P., Pompon D., et al. J. Pharmacol. Exp. Ther. 1993, 265:366-372.
13. Black M., Mitchell J.R., Zimmerman H.J., Ishak K.G., Epler G.R. Gastroenterology 1975, 69:289-302.
14. Bleibel W., Kim S., D'Silva K., Lemmer E.R. Dig. Dis. Sci. 2007, 52:2463-2471.
15. Boelsterli U.A. Drug Saf. 2002, 25:633-648.
16. Boelsterli U.A. Curr. Drug Metab. 2002, 3:439-450.
17. Boelsterli U.A. Toxicol. Appl. Pharmacol. 2003, 192:307-322.
18. Boelsterli U.A. Curr. Opin. Drug Discov. Devel. 2003, 6:81-91.
19. Boelsterli U.A. Toxicol. Mech. Methods 2003, 13:3-20.
20. Boelsterli U.A. Drug-Induced Liver Disease 2003, 345-375. Marcel Dekker, New York. N. Kaplowitz, L. DeLeve (Eds.).
21. Boelsterli U.A., Lee Y.H. Mitochondrial Dysfunction in Drug-Induced Toxicity 2007, Wiley, Hoboken, NJ. Y. Will, J.A. Dykens (Eds.).
22. Boelsterli U.A., Lim P.L.K. Toxicol. Appl. Pharmacol. 2007, 220:92-107.
23. Bourdi M., Gautier J., Mircheva J., Larrey D., Guillouzo A., Andre C., Belloc C., Beaune P. Mol. Pharmacol. 1992, 42:280-285.
24. Bourdi M., Masubuchi Y., Reilly T.P., Amouzadeh H.R., Martin J.L., George J.W., Shah A.G., Pohl L.R. Hepatology 2002, 35:289-298.
25. Buchweitz J.P., Ganey P.E., Bursian S.J., Roth R.A. J. Pharmacol. Exp. Ther. 2002, 300:460-467.
26. Buettner G.R., Ng C.F., Wang M., Rodgers V.G.J., Schafer F.Q. Free Radic. Biol. Med. 2006, 41:1338-1350.
27. Chinnery P.F., Johnson M.A., Wardell T.M., Singh-Kler R., Hayes C., Brown D.T., Taylor R.W., Bindoff L.A., Turnbull D.M. Ann. Neurol. 2000, 48:188-193.
28. Chipuk J.E., Bouchier-Hayes L., Green D.R. Cell Death Differ. 2006, 13:1396-1402.
29. Cho H.J., Koh W.J., Ryu Y.J., Ki C.S., Nam M.H., Kim J.W., Lee S.Y. Tuberculosis 2007, 87:551-556.
30. Chowdhury A., Santra A., Bhattacharjee K., Ghatak S., Saha D.R., Dhali G.K. J. Hepatol. 2006, 45:117-126.
31. Coe K.J., Jia Y., Ho H.K., Rademacher P., Bammler T.K., Beyer R.P., Farin F.M., Woodke L., Plymate S.R., Fausto N., et al. Chem. Res. Toxicol. 2007, 20:1277-1290.
32. Crawford E.D., Eisenberger M.A., McLeod D.G., Spaulding J.T., Benson R., Dorr F.A., Blumenstein B.A., Davis M.A., Goodman P.J. N. Engl. J. Med. 1989, 321:419-424.
33. Daly A.K., Aithal G.P., Leathart J.B.S., Swainsbury R.A., Dang T.S., Day C.P. Gastroenterology 2007, 132:272-281.
34. De Abajo F.J., Montero D., Madurga M., Garcia Rodriguez L.A. Br. J. Clin. Pharmacol. 2004, 58:71-80.
35. De la Iglesia F.A., Haskins J.R., Feuer G. Drug-Induced Liver Disease 2003, 549-592. Marcel Dekker, New York. N. Kaplowitz, L. DeLeve (Eds.).
36. DeLeve L. Drug-Induced Liver Disease 2007, 291-305. Informa Healthcare, New York. N. Kaplowitz, L. DeLeve (Eds.).
37. Den Brinker M., Wit F.W.N.M., Wertheim-van Dillen P.M., Jurriaans S., Weel J., van Leeuwen R., Pakker N.G., Reiss P., Danner S.A., Weverling G.J., et al. AIDS 2000, 14:2895-2902.
38. Deng X., Stachlewitz R.F., Liguori M.J., Blomme E.A., Waring J.F., Luyendyk J.P., Maddox J.F., Ganey P.A., Roth R.A. Toxicol. Sci. 2006, 90(Suppl.):350-351.
39. Deng X., Stachlewitz R.F., Liguori M.J., Blomme E.A., Waring J.F., Luyendyk J.P., Maddox J.F., Ganey P.A., Roth R.A. J. Pharmacol. Exp. Ther. 2006, 319:1191-1199.
40. Denis L.J., Griffiths K. Semin. Surg. Oncol. 2000, 18:52-74.
41. Dickinson D.S., Bailey W.C., Hirschowitz B.I., Soong S.J., Eidus L., Hodgkin M.M. J. Clin. Gastroenterol. 1981, 3:271-279.
42. Dykens J.A., Marroquin L.D., Will Y. Expert Rev. Mol. Diagn. 2007, 7:161-175.
43. Eaton D.L., Klaassen C.D. Casarett and Doull's Toxicology. The Basic Science of Poisons 1996, 13-33. McGraw-Hill, New York. 5th ed. C.D. Klaassen (Ed.).
44. El-Serag H.B., Everhart J.E. Gastroenterology 2002, 122:1822-1828.
45. Faich G.A., Moseley R.H. Pharmacoepidemiol. Drug Saf. 2001, 10:537-547.
46. Fattinger K., Funk C., Pantze M., Weber C., Reichen J., Stieger B., Meier P.J. Clin. Pharmacol. Ther. 2001, 69:223-231.
47. Fau D., Eugene D., Berson A., Letteron P., Fromenty B., Fisch C., Pessayre D. J. Pharmacol. Exp. Ther. 1994, 269:954-962.
48. Fischl M.A., Dickinson G.M., La Voie L. J. Am. Med. Assoc. 1988, 259:1185-1189.
49. Fontana R.J., Shakil A.O., Greenson J.K., Boyd I., Lee W.M. Dig. Dis. Sci. 2005, 50:1785-1790.
50. Fountain F.F., Tolley E., Chrisman C.R., Self T.H. Chest 2005, 128:116-123.
51. Fromenty B., Pessayre D. Pharmacol. Ther. 1995, 67:101-154.
52. Funk C., Ponelle C., Scheuermann G., Pantze M. Mol. Pharmacol. 2001, 59:627-635.
53. Galan M.V., Potts J.A., Silverman A.L., Gordon S.C. J. Clin. Gastroenterol. 2005, 39:64-67.
54. Ganey P.A., Luyendyk J.P., Maddox J.F., Roth R.A. Chem. Biol. Interact. 2004, 150:35-51.
55. Gao B., Jeong W.I., Tian Z. Hepatology 2008, 47:729-736.
56. Gao J., Garulacan L.A., Storm S.M., Hefta S.A., Opiteck G.J., Lin J.H., Moulin F., Dambach D.M. Toxicol. In Vitro 2004, 18:533-541.
57. Garcia Rodriguez L.A., Stricker B.H., Zimmerman H.J. Arch. Intern. Med. 1996, 156:1327-1332.
58. Garcia Rodriguez L.A., Williams R., Derby L.E., Dean A.D., Jick H. Arch. Intern. Med. 1994, 154:311-316.
59. Garibaldi R.A., Drusin R.E., Ferebee S.H., Gregg M.B. Am. Rev. Respir. Dis. 1972, 106:357-365.
60. Genter M.B., Clay C.D., Dalton T.P., Dong H., Nebert D.W., Shertzer H.G. Biochem. Biophys. Res. Commun. 2006, 342:1375-1381.
61. Gomez J.L., Dupont A., Cusan L., Tremblay M., Suburu R., Lemay M., Labrie F. Am. J. Med. 1992, 92:465-470.
62. Graham D.J., Green L., Senior J.R., Nourjah P. Am. J. Med. 2003, 114:299-306.
63. Grillo M.P., Hua F., Knutson C.G., Ware J.A., Li C. Chem. Res. Toxicol. 2003, 16:1410-1417.
64. Grillo M.P., Knutson C.G., Sanders P.E., Waldon D.J., Hua F., Ware J.A. Drug Metab. Dispos. 2003, 31:1327-1336.
65. Gunawan B.K., Kaplowitz N. Clin. Liver Dis. 2007, 11:459-475.
66. Hart W., Stricker B.H. Ann. Intern. Med. 1989, 110:943-944.
67. He K., Talaat R.E., Pool W.F., Reily M.D., Reed J.E., Bridges A.J., Woolf T.F. Drug Metab. Dispos. 2004, 32:639-646.
68. Helfgott S.M., Sandberg-Cook J., Zakim D., Nestler J. J. Am. Med. Assoc. 1990, 264:2660-2662.
69. Holt M.P., Ju C. AAPS J. 2006, 8:E48-E54.
70. Huang Y.S., Chern H.D., Su W.J., Wu J.C., Chang S.C., Chiang C.H., Chang F.Y., Lee S.D. Hepatology 2003, 37:924-930.
71. Huang Y.S., Chern H.D., Su W.J., Wu J.C., Lai S.L., Yang S.Y., Chang F.Y., Lee S.D. Hepatology 2002, 35:883-889.
72. Huang Y.S., Su W.J.Y.H.H., Chen C.Y., Chang F.Y.H.C.L., Lee S.D. J. Hepatol. 2007, 47:128-134.
73. Hunt C.M., Papay J.I., Edwards R.I., Theodore D., Alpers D.H., Dollery C., DeBruin T.W., Adkison K.K., Stirnadel H.A., Gibbs T.G. Regul. Toxicol. Pharmacol. 2007, 49:90-100.
74. Hussaini S.H., Farrington E.A. Expert Opin. Drug Saf. 2007, 6:673-684.
75. Hussaini S.H., O'Brien C.S., Despott E.J., Dalton H.R. Eur. J. Gastroenterol. Hepatol. 2007, 19:15-20.
76. Iravani A., Richard G.A. Antimicrob. Agents Chemother. 1986, 29:107-111.
77. Ishida Y., Kondo T., Ohshima T., Fujiwara H., Iwakura Y., Mukaida N. FASEB J. 2002, 16:1227-1236.
78. Iwanaga T., Nakakariya M., Yabuuchi H., Maeda T., Tamai I. Biol. Pharm. Bull. 2007, 30:739-744.
79. Jansen P.L.M., Strautnieks S.S., Jacquemin E., Hadchouel M., Sokal E.M., Hooiveld G.J., Koning J.H., De Jager-Krikken A., Kuipers F., Stellard F. Gastroenterology 1999, 117:1370-1379.
80. Ju C., Uetrecht J.P. Curr. Drug Metab. 2002, 3:367-377.
81. Kaplowitz N. Nat. Rev. Drug Discov. 2005, 4:489-499.
82. Kashimshetty R., Desai V.G., Kale V.M., Lee T., Moland C.L., Branham W.S., New L.S., Chan E.C.Y., Younis H., Boelsterli U.A. Toxicol. Appl. Pharmacol 2009, doi:10.1016/j.taap.2009.05.007.
83. Kass G.E.N. Chem. Biol. Interact. 2006, 163:145-159.
84. Kassahun K., Pearson P.G., Tang W., McIntosh I., Leung K., Elmore C., Dean D., Wang R., Doss G., Baillie T.A. Chem. Res. Toxicol. 2001, 14:62-70.
85. Kobayashi A., Kang M.I., Watai Y., Tong K.I., Shibata T., Uchida K., Yamamoto M. Mol. Cell. Biol. 2006, 26:221-229.
86. Kopanoff D.E., Snider D.E., Caras G.J. Am. Rev. Respir. Dis. 1978, 117:991-1001.
87. Kraus I., Vitezic D., Oguic R. Int. J. Clin. Pharmacol. Ther. 2001, 39:395-399.
88. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., Hofer T., Seo A.Y., Sullivan R., Jobling W.A. Science 2005, 309:481-484.
89. Lammert C., Bjornsson E., Saha C., Chalasani N.P. Hepatology 2007, 46:808A.
90. LaRocca D., Lehmann D.F., Perl A., Ozawa T., Holohan P.D. Br. J. Clin. Pharmacol. 2006, 63:249-251.
91. Larrey D., Vial T., Micaleff A., Babany G., Morichau-Beauchant M., Michel H., Benhamou J.P. Gut 1992, 33:368-371.
92. Lecoeur S., Andre C., Beaune P.H. Mol. Pharmacol. 1996, 50:326-333.
93. Lee H.W., Chung J.P., Lee K.S., Kim K.C., Chon C.Y., Park I.S., Kim H.G. Yonsei Med. J. 1996, 37:225-229.
94. Lee W.M. Hepatology 2007, 46:966-970.
95. Lee Y.H., Chung M.C.M., Lin Q., Boelsterli U.A. Toxicol. Appl. pharmacol. 2008, 231:43-51.
96. Lemozit J.P., De La Rhodiere G.P., Lapeyre-Mestre M., Bagheri H., Montastruc J.L. Br. J. Clin. Pharmacol. 1996, 41:166-168.
97. Lewis J.E., Mello P., Knauer C.M. West. J. Med. 1975, 122:371-376.
98. Li A.P. Chem. Biol. Interact. 2002, 142:7-23.
99. Liguori M.J., Waring J.F. Expert Opin. Drug Metab. Toxicol. 2006, 2:835-846.
100. Lim M.S., Lim P.L.K., Gupta R., Boelsterli U.A. Toxicol. Appl. Pharmacol. 2006, 217:322-331.
101. Lim P.L.K., Liu J., Go M.L., Boelsterli U.A. Toxicol. Sci. 2008, 101:341-349.
102. Lucena M.I., Andrade R.J., Fernandez M.C., Pachkoria K., Pelaez G., Duran J.A., Villar M., Rodrigo L., Romero-Gomez M., Planas R., et al. Hepatology 2006, 44:850-856.
103. Lund F., Rasmussen F. Br. J. Urol. 1988, 61:140-142.
104. Luyendyk J.P., Maddox J.F., Cosma G.N., Ganey P.A., Cockerell G.L., Roth R.A. J. Pharmacol. Exp. Ther. 2003, 307:9-16.
105. MacDonald M.G., McGrath P.P., McMartin D.N. Pediatr. Res. 1984, 18:181-187.
106. Maddrey W.C., Boitnott J.K. Ann. Intern. Med. 1973, 79:1-12.
107. Manwaring N., Jones M.M., Wang J.J., Rochtchina E., Howard C., Mitchell P., Sue C.M. Mitochondrion 2007, 7:230-233.
108. Masubuchi Y., Bourdi M., Reilly T.P., Graf M.L., George J.W., Pohl L.R. Biochem. Biophys. Res. Commun. 2003, 304:207-212.
109. Masubuchi Y., Kano S., Horie T. Toxicology 2006, 222:233-239.
110. Masubuchi Y., Nakayama S., Horie T. Hepatology 2002, 35:544-551.
111. Matsuzaki Y., Nagai D., Ichimura E., Goda R., Tomura A., Doi M., Nishikawa K. J. Gastroenterol. 2006, 41:231-239.
112. Matzinger P. Annu. Rev. Immunol. 1994, 12:991-1045.
113. Merlani G., Fox M., Oehen H.P., Cathomas G., Renner E.L., Fattinger K., Schneemann M., Kullak-Ublick G.A. Eur. J. Clin. Pharmacol. 2001, 57:321-326.
114. Millard P.S., Wilcosky T.C., Reade-Christopher S.J., Weber D.J. West. J. Med. 1996, 164:486-491.
115. Mitchell P. Lancet 1997, 350:1.
116. Monshouwer M., Hoebe K.H.N. Toxicol. In Vitro 2003, 17:681-686.
117. Murphy M.P., Smith R.A.J. Annu. Rev. Pharmacol. Toxicol. 2007, 47:629-656.
118. Nadanaciva S., Dykens J.A., Bernal A., Capaldi R.A., Will Y. Toxicol. Appl. Pharmacol. 2007, 223:277-287.
119. Nathani M.G., Mutchnick M.G., Tynes D.J., Ehrinpreis M.N. Am. J. Gastroenterol. 1998, 93:1363-1365.
120. Navarro V.J., Senior J.R. N. Engl. J. Med. 2006, 354:731-739.
121. Nebert D.W. Toxicol. Appl. Pharmacol. 2005, 207:S34-S42.
122. Nebert D.W., Roe A.L., Vandale S.E., Bingham E., Oakley G.G. Genet. Med. 2002, 4:62-70.
123. O'Donohue J., Oien K.A., Donaldson P., Underhill J., Clare M., MacSween R.N., Mills P.R. Gut 2000, 47:717-720.
124. Ong M.M.K., Latchoumycandane C., Boelsterli U.A. Toxicol. Sci. 2007, 97:205-213.
125. Ong M.M.K., Wang A.S., Leow K.Y., Khoo Y.M., Boelsterli U.A. Free Radic. Biol. Med. 2006, 40:420-429.
126. Ormerod L.P., Skinner C., Wales J. Thorax 1996, 51:111-113.
127. Osculati A., Castiglioni C. Lancet 2006, 367:1140-1141.
128. Ozono S., Yamaguchi A., Mochizuki H., Kawakami T., Fujimoto K., Otani T., Yoshida K., Ichinei M., Yamashita T., Hirao Y. Prostate Cancer Prostatic. Dis. 2002, 5:128-131.
129. Park B.K., Pirmohamed M., Kitteringham N.R. Chem. Res. Toxicol. 1998, 11:969-988.
130. Perez V.I., Lew C.M., Cortez L.A., Webb C.R., Rodriguez M., Liu Y., Qi W., Li Y., Chaudhuri A., Van Remmen H., et al. Free Radic. Biol. Med. 2008, 44:882-892.
131. Pessayre D., Fromenty B. J. Hepatol. 2005, 42:928-940.
132. Pessayre D., Fromenty B., Mansouri A., Berson A. Drug-Induced Liver Disease 2007, 49-84. Informa Healthcare, New York. N. Kaplowitz, L. DeLeve (Eds.).
133. Pirmohamed M., Park B.K. Trends Pharmacol. Sci. 2001, 22:298-305.
134. Pohl L.R., Satoh H., Christ D.D., Kenna J.G. Annu. Rev. Pharmacol. 1988, 28:367-387.
135. Polson J., Lee W.M. Liver Transpl. 2007, 13:1362-1363.
136. Pontiroli L., Sartori M., Pittau S., Morelli S., Boldorini R., Albano E. Ital. J. Gastroenterol. Hepatol. 1998, 30:310-314.
137. Prattichizzo F.A. Am. J. Med. 1994, 96:392-393.
138. Reilly T.P., Brady J.N., Marchik M.R., Bourdi M., George J.W., Radonovich M.F., Pise-Masison C.A., Pohl L.R. Chem. Res. Toxicol. 2001, 14:1620-1628.
139. Renton K.W., Armstrong S.G. Immunotoxicology and Immunopharmacology 1994, 501-512. Raven Press, New York. 2nd ed. J.H. Dean, M.I. Luster, A.E. Munson, I. Kimber (Eds.).
140. Riley T.R., Smith J.P. Am. J. Gastroenterol. 1998, 93:1563-1565.
141. Rost D., Herrmann T., Sauer P., Schmidts H.L., Stieger B., Meier P.J., Stremmel W., Stiehl A. Hepatology 2003, 38:187-195.
142. Roth R.A., Harkema J.R., Pestka J.P., Ganey P.E. Toxicol. Appl. Pharmacol. 1997, 147:300-311.
143. Roy B., Chawdhury A., Kundu S., Santra A., Dey B., Chakraborty M., Majumder P.P. J. Gastroenterol. Hepatol. 2001, 16:1033-1037.
144. Russo M.W., Galanko J.A., Shreshtha R., Fried M.W., Watkins P. Liver Transpl. 2004, 10:1018-1023.
145. Salama A., Göttsche B., Mueller-Eckhardt C. Br. J. Haematol. 1991, 77:546-549.
146. Salvo F., Polimeni G., Moretti U., Conforti A., Leone R., Leoni O., Motola D., Dusi G., Caputi A.P. J. Antimicrob. Chemother. 2007, 60:121-126.
147. Scharer L., Smith J.P. Ann. Intern. Med. 1969, 71:1113-1120.
148. Schattner A., Sokolovskaya N., Cohen J. J. Intern. Med. 2000, 247:153-155.
149. Schwartz S., Raskin P., Fonseca V., Graveline J.F. N. Engl. J. Med. 1998, 338:861-866.
150. Sgro C., Clinard F., Ouazir K., Chanay H., Allard C., Guilleminet C., Lenoir C., Lemoine A., Hillon P. Hepatology 2002, 36:451-455.
151. Shakya R., Rao B.S., Shrestha B. Ann. Pharmacother. 2004, 38:1074-1079.
152. Shanske S., Wong L.J.C. Mitochondrion 2004, 4:403-415.
153. Shaw P.J., Hopfensperger M.J., Ganey P.E., Roth R.A. Toxicol. Sci. 2007, 100:259-266.
154. Shibuya A., Watanabe M., Fujita Y., Saigenji K., Kuwao S., Takahashi H., Takeuchi H. Diabetes Care 1998, 21:2140-2143.
155. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., Mizuno Y. Biochem. Biophys. Res. Commun. 1996, 226:561-565.
156. Simon T., Becquemont L., Mary-Krause M., deWaziers I., Beaune P., Funck-Brentano C., Jaillon P. Clin. Pharmacol. Ther. 2000, 67:432-437.
157. Smith K.S., Smith P.L., Heady T.N., Trugman J.M., Harman W.D., Macdonald T.L. Chem. Res. Toxicol. 2003, 16:123-128.
158. Sodeman T., Bronk S.F., Roberts P.J., Miyoshi H., Gores G.J. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278:G992-G999.
159. Steinsapir J., Mora G., Muldoon T.G. Biochim. Biophys. Acta 1991, 1094:103-112.
160. Strange R.C., Jones P.W., Fryer A.A. Toxicol. Lett. 2000, 112-113:357-363.
161. Sulkowski M.S., Thomas D.L., Chaisson R.E., Moore R.D. J. Am. Med. Assoc. 2000, 283:74-80.
162. Sutton A., Imbert A., Igoudjil A., Descatoire V., Cazanave S., Pessayre D., Degoul F. Pharmacogenet. Genomics 2005, 15:311-319.
163. Sutton A., Koury H., Prip-Buus C., Cepanec C., Pessayre D., Degoul F. Pharmacogenetics 2003, 13:145-157.
164. Tarantino G., Conca P., Basile V., Gentile A., Capone D., Polichetti G., Leo E. Hepatol. Res. 2007, 37:410-415.
165. Tay V.K., Wang A.S., Leow K.Y., Ong M.M., Wong K.P., Boelsterli U.A. Free Radic. Biol. Med. 2005, 39:949-959.
166. Traversa G., Bianchi C., Da Cas R., Abraha I., Menniti-Ippolito F., Venegoni M. Br. J. Med. 2003, 327:18-22.
167. Rezulin to be Withdrawn from the Market 21 March 2000, U.S. Food and Drug Administration. http://www.fda.gov/bbs/topics/NEWS/NEW00721.html.
168. Uetrecht J. Annu. Rev. Pharmacol. Toxicol. 2007, 47:513-539.
169. Uetrecht J.P. Chem. Res. Toxicol. 1999, 12:387-395.
170. Uetrecht J.P. Curr. Drug Metab. 2000, 1:133-141.
171. Walgren J.L., Mitchell M.D., Thompson D.C. Crit. Rev. Toxicol. 2005, 35:325-361.
172. Wallace K.B., Starkov A.A. Annu. Rev. Pharmacol. Toxicol. 2000, 40:353-388.
173. Wang T., Shankar K., Ronis M.J., Mehendale H.M. Crit. Rev. Toxicol. 2007, 37:413-459.
174. Waring J.F., Anderson M.G. Curr. Opin. Drug Discov. Devel. 2005, 8:59-65.
175. Waring J.F., Liguori M.J., Luyendyk J.P., Maddox J.F., Ganey P.A., Stachlewitz R.F., North C., Blomme E.A., Roth R.A. Toxicol. Sci. 2006, 90(Suppl.):350.
176. Watanabe I., Tomita A., Shimizu M., Sugawara M., Yasumo H., Koishi R., Takahashi T., Miyoshi K., Nakamura K., Izumi T. Clin. Pharmacol. Ther. 2003, 73:435-455.
177. Watkins P. Toxicol. Pathol. 2005, 33:1-5.
178. Watkins P.B., Seeff L.B. Hepatology 2006, 43:618-631.
179. Watkins P.B., Whitcomb R.W. N. Engl. J. Med. 1998, 338:916-917.
180. Welch K.D., Wen B., Goodlett D.R., Yi E.C., Lee H., Reilly T.P., Nelson S.D., Pohl L.R. Chem. Res. Toxicol. 2005, 18:924-933.
181. Wilke R., Lin D.W., Roden D.M., Watkins P., Flockhart D., Zineh I., Giacomini K.M., Krauss R.M. Nat. Rev. Drug Discov. 2007, 6:904-916.
182. Williams D.P., Park B.K. Drug Discov. Today 2003, 8:1044-1050.
183. Wysowski D.K., Fourcroy J.L. J. Urol. 1996, 155:209-212.
184. Wysowski D.K., Freiman J.P., Tourtelot J.B., Horton M.L. Ann. Intern. Med. 1993, 118:860-864.
185. Yamanaka H., Gatanaga H., Kosalaraksa P., Matsuoka-Aizawa S., Takahashi T., Kimura S., Oka S. J. Infect. Dis. 2007, 195:1419-1425.
186. Yee D., Valiquette C., Pelletier M., Parisien I., Rocher I., Menzies D. Am. J. Respir. Crit. Care Med. 2003, 167:1472-1477.
187. Zimmerman H.J. Hepatotoxicity. The Adverse Effects of Drugs and Other Chemicals on the Liver 1999, Lippincott Williams & Wilkins, Philadelphia, PA. 2nd ed.